AI
AI

Tag: Subcutaneous

FDA Approves Biologics License Application for Subcutaneous Maintenance Dosing of Leqembi® (lecanemab-irmb) in the U.S. – Investing.com

Photo credit: www.investing.com FDA Accepts Biologics License Application for Leqembi's Subcutaneous Autoinjector On January 13, 2025, BioArctic AB (publ) announced that...